The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates RadiotherapyKatrine Ingelshed, Saikiran K. Sedimbi|Cancer Research Communications|2022Cited by 14